APELLIS PHARMACEUTICALS INC (APLS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for APLS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| APLS | Independent Director | 53 | ["Co-Founder and Managing Partner, Epidarex Capital", "Founder and Managing Partner, Masa Life Science Ventures", "Extensive investment and business experience", "20 years of experience in early-stage life science companies"] | ["Audit", "Nominating and Corporate Governance"] | 2025 |
Biography sourced from the proxy statement filing.
Independent Director since 2010 Age: 53 Committees: Audit Nominating and Corporate Governance Experience Co-Founder and Managing Partner, Epidarex Capital, an early-stage venture fund platform with approximately $250 million in assets under management (July 2010 present) Founder and Managing Partner, Masa Life Science Ventures, LP, an early-stage venture fund that successfully built an international portfolio of leading life science and health technology companies (2005 2010) Qualifications Extensive investment and business experience, including 20 years of experience successfully building early-stage life science companies and delivering competitive returns to international investors Education M.B.A., Columbia Business School, where he was the R.C. Kopf British-American Fellow in international business M.A., Political Economy, with Honors, University of Glasgow M.A., International Relations, Maxwell School of Citizenship and Public Affairs at Syracuse University Other Boards Clyde Biosciences (private, 2015 present) Edinburgh Molecular Imaging, Ltd. (private, 2014 2022) Inspiring Scotland (chairman, non-profit, 2015 present) Lario Therapeutics (private, 2023 present) Theolytics Ltd. (private, 2021 2023)